Halozyme Reports Q3 Results and Raises 2026 Guidance
Total revenue rose 39% year over year, while royalty revenue increased 44%. Halozyme raised its 2026 total revenue and royalty revenue guidance ranges.
Story updates
09:06:48 PM UTC
SquawkNews
Q3 revenue rose 39% YoY to $493M and royalty revenue rose 44% to $341M. Halozyme raised 2026 guidance: revenue to $1.860—$1.925B and non-GAAP diluted EPS to $8.75—$9.05; the release cites YoY growth ranges of 33%—38% and 111%—118%, respectively.Material DetailsContext by AI AnalystThis is a mid-cyc…
Total Revenue Increased 39% YOY to $493 millionRoyalty Revenue Increased 44% YOY to $341 millionRaising 2026 Financial Guidance Ranges:Total Revenue of $1.860 - $1.925 billion, YOY Growth of 33% - 38%Royalty Revenue of $1.235 - $1.255 billion, YOY Growth of 42% - 45%Adjusted EBITDA of $1.240 - $1.2…